Detalhe da pesquisa
1.
Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial.
Br J Haematol
; 195(4): 612-620, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34291449
2.
Transcranial Doppler velocity among Jamaican children with sickle cell anaemia: determining the significance of haematological values and nutrition.
Br J Haematol
; 181(2): 242-251, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29504121
3.
Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trial.
Am J Hematol
; 90(12): 1099-105, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26414435
4.
EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia.
JMIR Res Protoc
; 5(3): e185, 2016 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27619954